1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Epilepsy Drugs Market Landscape

4.1 Overview

5. North America Epilepsy Drugs Market - Key Industry Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Epilepsy

5.1.2 Increasing Number of Elderly People

5.2 Market Restraints

5.2.1 Recall of Therapeutic Products

5.3 Market Opportunities

5.3.1 Several Epilepsy Drugs Nearing Patent Expiration

5.4 Future Trends

5.4.1 Increasing Product Approvals

5.5 Impact Analysis

6. Epilepsy Drugs Market - North America Market Analysis

6.1 Overview

6.2 North America Epilepsy Drugs Market Revenue (US$ Mn), 2022 - 2030

7. North America Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Treatment

7.1 Overview

7.2 North America Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)

7.3 First Generation Antiepileptics

7.3.1 Overview

7.3.2 First Generation Antiepileptics: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Second Generation Anti-epileptics

7.4.1 Overview

7.4.2 Second Generation Anti-epileptics: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Third Generation Anti-epileptics

7.5.1 Overview

7.5.2 Third Generation Anti-epileptics: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 North America Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

8.3 Hospital Pharmacy

8.3.1 Overview

8.3.2 Hospital Pharmacy: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Retail Pharmacy Stores

8.4.1 Overview

8.4.2 Retail Pharmacy Stores: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Epilepsy Drugs Market - Revenue and Forecast to 2030 - Country Analysis

9.1 North America Epilepsy Drugs Market

9.1.1.1 US: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.1 Overview

9.1.1.1.2 US: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.3 US: North America Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.1.4 US: North America Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.2 Canada: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.1 Overview

9.1.1.2.2 Canada: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.3 Canada: North America Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.2.4 Canada: North America Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.3 Mexico: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.1 Overview

9.1.1.3.2 Mexico: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.3 Mexico: North America Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.3.4 Mexico: North America Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Epilepsy Drugs Market-Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Epilepsy Drugs Market

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 UCB SA

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Novartis AG

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Pfizer Inc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 GSK Plc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Abbott Laboratories

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Sanofi SA

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Sumitomo Pharma America Inc.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Teva Pharmaceutical Industries Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Catalyst Pharmaceuticals Inc

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Alkem Laboratories Ltd

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. North America Epilepsy Drugs Market Segmentation

Table 2. US: North America Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 3. US: North America Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 4. Canada: North America Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 5. Canada: North America Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 6. Mexico: North America Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 7. Mexico: North America Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 8. Recent Inorganic Growth Strategies in the Epilepsy Drugs Market

Table 9. Recent Organic Growth Strategies in the Epilepsy Drugs Market

Table 10. Glossary of Terms, North America Epilepsy Drugs Market

List of Figures

Figure 1. North America Epilepsy Drugs Market Segmentation, By Country

Figure 2. North America Epilepsy Drugs Market: Key Industry Dynamics

Figure 3. North America Epilepsy Drugs Market: Impact Analysis of Drivers and Restraints

Figure 4. North America Epilepsy Drugs Market Revenue (US$ Mn), 2022 - 2030

Figure 5. North America Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)

Figure 6. First Generation Anti-epileptics: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Second Generation Anti-epileptics: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Third Generation Anti-epileptics: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

Figure 10. Hospital Pharmacy: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Retail Pharmacy Stores: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Others: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. North America Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)

Figure 14. North America Epilepsy Drugs Market, by Country, 2022 & 2030 (%)

Figure 15. US: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Canada: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Mexico: North America Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Growth Strategies in the Epilepsy Drugs Market